医学
头颈部鳞状细胞癌
头颈部癌
原发性肿瘤
肿瘤科
相伴的
内科学
危险系数
放化疗
放射治疗
多元分析
癌症
核医学
置信区间
转移
作者
J. Knegjens,Michael Hauptmann,Frank A. Pameijer,Alfons J. M. Balm,Frank Hoebers,Josien A. de Bois,Johannes H.A.M. Kaanders,Carla M. van Herpen,C. Verhoef,Oda B. Wijers,Ruud Wiggenraad,Jan Buter,C. Rasch
出处
期刊:Head & neck
[Wiley]
日期:2010-07-13
卷期号:33 (3): 375-382
被引量:94
摘要
Abstract Background Tumor volume is an important predictor of outcome in radiotherapy alone. Its significance in concomitant chemoradiation (CCRT) is much less clear. We analyzed the prognostic value of primary tumor volume for advanced head and neck squamous cell carcinoma (HNSCC) treated with CCRT. Methods Three hundred sixty patients treated with definitive CCRT for advanced HNSCC were selected. The pretreatment MRI or CT scan was used to calculate the primary tumor volume. Median follow‐up was 19.8 months. Results The average primary tumor volume was 37.0 cm 3 (range, 2.1–182.7 cm 3 ; median, 28.7 cm 3 ). Multivariate analysis showed a significant effect of tumor volume on local control. The hazard ratio for a local recurrence increased by 14% per 10 cm 3 volume increase (95% CI, 8% to 21%). There was no significant independent effect of T and N status on local control. Conclusion For advanced HNSCC, tumor volume is more powerful for predicting outcome after CCRT than TNM status. © 2010 Wiley Periodicals, Inc. Head Neck, 2010
科研通智能强力驱动
Strongly Powered by AbleSci AI